top of page
  • Rick

FDA Drug Recall

Updated: May 20, 2021

As of May 5, 2021, Hospira has issued a recall of specific lots of 0.5% Bupivacaine Hydrochloride and Lidocaine HCL. If you have either lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 0.5% 30 mL or lot EG8933 of Lidocaine HCl Injection USP, 1% 30 mL, it should be removed from stock immediately and the manufacturer (or the dealer through whom it was purchased) should be contacted. Hospira has identified mislabeling whereby a portion of each lot was incorrectly labeled as the other product. This issue was identified as part of the investigation of a confirmed customer report.


For further information, contact Hospira, or see the full report from the FDA.




14 views

Recent Posts

See All

FDA Recall of certain Monoject Syringes

Cardinal Health has announced a recall of certain sizes of their Monoject leur-lock syringes. in concert with the FDA, they have issued a safety communication to remove the following sizes of Cardinal

Comentários


bottom of page